At Vivani we are developing our novel NanoPortal™ implant technology for delivering the intended dose of medication steadily over extended periods of time. It has been engineered with the goal of avoiding challenges that may be associated with fluctuating drug delivery.

Sep 25, 2024 · Vivani Medical is an emerging biopharmaceutical company developing a pipeline of miniature, long-term drug implants with its proprietary NanoPortal™ platform technology for obesity/weight management and other chronic diseases.

Vivani™ is an innovative, near-clinical stage biopharmaceutical company. Leveraging our proprietary NanoPortal™ platform technology, we are developing a portfolio of miniature, long-term drug implants to address two main barriers of optimal chronic disease treatment: medication non-adherence and tolerability.

Mar 12, 2025 · Spin-off will allow Vivani to focus on developing miniature, ultra long-acting GLP-1 implants for chronic weight management and type 2 diabetes with once or twice-yearly administration

1 day ago · Vivani’s lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in obese or overweight individuals. Vivani’s emerging pipeline includes NPM-139 (semaglutide implant) which is also under development for chronic weight management in obese and overweight individuals. ...

Vivani Organic Chocolate is a brand of chocolate created by EcoFinia GmbH, a subsidiary of Ludwig Weinrich GmbH & Co. KG., based in Herford, Germany. First introduced in 2000 at the international organic food fair, BioFach, Vivani chocolate is predominantly sold in organic supermarkets and shops, where it claims market leadership in organic ...

22 hours ago · About Vivani Medical, Inc. Leveraging its proprietary NanoPortal™ platform, Vivani develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Vivani’s lead program, NPM-115, is a six ...

1 day ago · Vivani will be presenting for 30 minutes starting at 2:20 pm Eastern Time. Please register at the following link to attend the conference and receive any updates released in follow up to the ...

Mar 13, 2025 · To learn more about Vivani or LIBERATE-1, the upcoming First-in-Human trial of our long-term GLP-1 implant, please fill out the form.

Mar 12, 2025 · Vivani aims to continue advancing its miniature GLP-1 therapeutic implants. The spin-off would enable Cortigent to continue progressing its brain implant devices to help people recover critical body functions.